Effects of irisin and exercise on adropin and betatrophin in a new metabolic syndrome model

References

• Aydin S. 2014. Three new players in energy regulation: preptin, adropin and irisin. Peptides. 56:94–110. doi: 10.1016/j.peptides.2014.03.021.
   PubMed Web of Science ®Google Scholar
• Aydin S. 2015. A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA. Peptides. 72:4–15. doi: 10.1016/j.peptides.2015.04.012.
   PubMed Web of Science ®Google Scholar
• Aydin S, Aksoy A, Aydin S, Kalayci M, Yilmaz M, Kuloglu T, Citil C, Catak Z. 2014. Todays and yesterdays of pathophysiology: biochemistry of metabolic syndrome and animal models. Nutrition. 30:1–9. doi: 10.1016/j.nut.2013.05.013.
   PubMed Web of Science ®Google Scholar
• Baldwin W, McRae S, Marek G, Wymer D, Pannu V, Baylis C, Johnson RJ, Sautin YY. 2011. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes. 60:1258–1269. doi: 10.2337/db10-0916.
   PubMed Web of Science ®Google Scholar
• Bozic J, Kumric M, Ticinovic Kurir T, Males I, Borovac JA, Martinovic D, Vilovic M. 2021. Role of adropin in cardiometabolic disorders: from pathophysiological mechanisms to therapeutic target. Biomedicines. 9:1407–1419. doi: 10.3390/biomedicines9101407.
   PubMed Web of Science ®Google Scholar
• Cahová M, Habart D, Olejár T, Berková Z, Papáčková Z, Daňková H, Lodererova A, Heczková M, Saudek F. 2017. Lipasin/Betatrophin is differentially expressed in liver and white adipose tissue without association with insulin resistance in Wistar and Goto-Kakizaki rats. Physiol Res. 66:273–281. doi: 10.33549/physiolres.933339.
   PubMed Web of Science ®Google Scholar
• Chen LY, Zhu WH, Chen ZW, Dai HL, Ren JJ, Chen JH, Chen LQ, Fang LZ. 2007. Relationship between hyperuricemia and metabolic syndrome. J Zhejiang Univ Sci B. 8:593–598. doi: 10.1631/jzus.2007.B0593.
   PubMedGoogle Scholar
• Cicero AFG, Fogacci F, Giovannini M, Grandi E, Rosticci M, D’Addato S, Borghi C. 2018. Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study. Sci Rep. 8:11529–11535. doi: 10.1038/s41598-018-29955-w.
   PubMed Web of Science ®Google Scholar
• Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH. 2008. The metabolic syndrome. Endocr Rev. 29:777–822. doi: 10.1210/er.2008-0024.
   PubMed Web of Science ®Google Scholar
• El-Mehi AE, Faried MA. 2020. Effect of high-fructose diet-induced metabolic syndrome on the pituitary-gonadal axis from adolescence through adulthood in male albino rats and the possible protective role of ginger extract. A biochemical, histological and immunohistochemical study. Folia Morphol. 79:690–708. doi: 10.5603/FM.a2019.0139.
   PubMed Web of Science ®Google Scholar
• Es-Haghi A, Al-Abyadh T, Mehrad-Majd H. 2021. The clinical value of serum adropin level in early detection of diabetic nephropathy. Kidney Blood Press Res. 46:734–740. doi: 10.1159/000519173.
   PubMedGoogle Scholar
• Feig DI, Madero M, Jalal DI, Sanchez-Lozada LG, Johnson RJ. 2013. Uric acid and the origins of hypertension. J Pediatr. 162:896–902. doi: 10.1016/j.jpeds.2012.12.078.
   PubMed Web of Science ®Google Scholar
• Ford ES, Li C, Cook S, Choi HK. 2007. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 115:2526–2532. doi: 10.1161/CIRCULATIONAHA.106.657627.
   PubMed Web of Science ®Google Scholar
• Gao S, McMillan RP, Zhu Q, Lopaschuk GD, Hulver MW, Butler AA. 2015. Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance. Mol Metab. 4:310–324. doi: 10.1016/j.molmet.2015.01.005.
   PubMed Web of Science ®Google Scholar
• Goli P, Riahi R, Daniali SS, Pourmirzaei M, Kelishadi R. 2020. Association of serum uric acid concentration with components of pediatric metabolic syndrome: a systematic review and meta-analysis. J Res Med Sci. 25:43–59. doi: 10.4103/jrms.JRMS_733_19.
   PubMed Web of Science ®Google Scholar
• Guo Q, Cao S, Wang X. 2022. Betatrophin and insulin resistance. Metabolites. 12:925–935. doi: 10.3390/metabo12100925.
   PubMed Web of Science ®Google Scholar
• Herath HMM, Weerasinghe NP, Weerarathna TP, Amarathunga A. 2018. A comparison of the prevalence of the metabolic syndrome among Sri Lankan patients with type 2 diabetes mellitus using WHO, NCEP-ATP III, and IDF definitions. Int J Chronic Dis. 2018:1–8. doi: 10.1155/2018/7813537.
   Google Scholar
• Hsu SM, Raine L, Fanger H. 1981. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 29:577–580. https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/doh-oct1983/.
   PubMed Web of Science ®Google Scholar
• Juna CF, Cho Y, Ham D, Joung H. 2021. Association of carbohydrate and fat intake with prevalence of metabolic syndrome can be modified by physical activity and physical environment in Ecuadorian adults: the ENSANUT-ECU Study. Nutrients. 13:1834–1848. doi: 10.3390/nu13061834.
   PubMed Web of Science ®Google Scholar
• Klein AV, Kiat H. 2015. The mechanisms underlying fructose-induced hypertension: a review. J Hypertens. 33:912–920. doi: 10.1097/HJH.0000000000000551.
   PubMed Web of Science ®Google Scholar
• Kolovou GD, Anagnostopoulou KK, Salpea KD, Mikhailidis DP. 2007. The prevalence of metabolic syndrome in various populations. Am J Med Sci. 333:362–371. doi: 10.1097/MAJ.0b013e318065c3a1.
   PubMed Web of Science ®Google Scholar
• Li S, Sun J, Hu W, Liu Y, Lin D, Duan H, Liu F. 2019. The association of serum and vitreous adropin concentrations with diabetic retinopathy. Ann Clin Biochem. 56:253–258. doi: 10.1177/0004563218820359.
   PubMed Web of Science ®Google Scholar
• Liu D, Li S, He H, Yu C, Li X, Liang L, Chen Y, Li J, Li J, Sun X, Tian H, An Z. 2017. Increased circulating full-length betatrophin levels in drug-naive metabolic syndrome. Oncotarget. 8:17510–17517. doi: 10.18632/oncotarget.15102.
   PubMedGoogle Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2002. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 106:3143–3421. PMID: 12485966. doi: 10.1161/circ.106.25.3143.
   PubMed Web of Science ®Google Scholar
• Parikh RM, Mohan V. 2012. Changing definitions of metabolic syndrome. Ind J Endocrinol Metab. 16:7–12. doi: 10.4103/2230-8210.91175.
   PubMedGoogle Scholar
• Perakakis N, Triantafyllou GA, Fernández-Real JM, Huh JY, Park KH, Seufert J, Mantzoros CS. 2017. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. 13:324–337. doi: 10.1038/nrendo.2016.221.
   PubMed Web of Science ®Google Scholar
• Raghow R. 2013. Betatrophin: a liver-derived hormone for the pancreatic β-cell proliferation. World J Diabetes. 4:234–237. doi: 10.4239/wjd.v4.i6.234.
   PubMedGoogle Scholar
• Sahin I, Aydin S, Ozkan Y, Dagli AF, Akin KO, Guzel SP, Catak Z, Ozercan MR. 2011. Diet-induced obesity suppresses ghrelin in rat gastrointestinal tract and serum. Mol Cell Biochem. 355:299–308. doi: 10.1007/s11010-011-0867-5.
   PubMed Web of Science ®Google Scholar
• Soltani S, Beigrezaei S, Malekahmadi M, Clark CCT, Abdollahi S. 2023. Circulating levels of adropin and diabetes: a systematic review and meta-analysis of observational studies. BMC Endocr Disord. 23:73–85. doi: 10.1186/s12902-023-01327-0.
   PubMed Web of Science ®Google Scholar
• Soltani Z, Rasheed K, Kapusta DR, Reisin E. 2013. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr Hypertens Rep. 15:175–181. doi: 10.1007/s11906-013-0344-5.
   PubMed Web of Science ®Google Scholar
• Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. 2008. Uric acid and the development of metabolic syndrome in women and men. Metabolism. 57:845–852. doi: 10.1016/j.metabol.2008.01.030.
   PubMed Web of Science ®Google Scholar
• Tavassoli H, Heidarianpour A. 2021. Associations between betatrophin with irisin and metabolic factors: effects of two exercise trainings in diabetic rats. Am J Med Sci. 362:496–505. doi: 10.1016/j.amjms.2021.05.023.
   PubMed Web of Science ®Google Scholar
• Tseng YH, Yeh YH, Chen WJ, Lin KH. 2014. Emerging regulation and function of betatrophin. Int J Mol Sci. 15:23640–23657. doi: 10.3390/ijms151223640.
   PubMed Web of Science ®Google Scholar
• Tsushima Y, Nishizawa H, Tochino Y, Nakatsuji H, Sekimoto R, Nagao H, Shirakura T, Kato K, Imaizumi K, Takahashi H, Tamura M, Maeda N, Funahashi T, Shimomura I. 2013. Uric acid secretion from adipose tissue and its increase in obesity. J Biol Chem. 288:27138–27149. doi: 10.1074/jbc.M113.485094.
   PubMed Web of Science ®Google Scholar
• Wang JY, Chen YL, Hsu CH, Tang SH, Wu CZ, Pei D. 2012. Predictive value of serum uric acid levels for the diagnosis of metabolic syndrome in adolescents. J Pediatr. 161:753–756. doi: 10.1016/j.jpeds.2012.03.036.
   PubMed Web of Science ®Google Scholar
• Willems AEM, Jong MS, van Beek AP, Nederhof E, van Dijk G. 2021. Effects of macronutrient intake in obesity: a meta-analysis of low-carbohydrate and low-fat diets on markers of the metabolic syndrome. Nutr Rev. 79:429–444. doi: 10.1093/nutrit/nuaa044.
   PubMed Web of Science ®Google Scholar
• Yavuz A, Aydin MA, Ugur K, Aydin S, Senol A, Baykus Y, Deniz R, Sahin İ, Yalcin MH, Gencer BT, Deniz YK, Ustebay S, Karagoz ZK, Emre E, Aydin S. 2023. Betatrophin, elabela, asprosin, glucagon and subfatin peptides in breast tissue, blood and milk in gestational diabetes. Biotech Histochem. 98:243–254. doi: 10.1080/10520295.2023.2176546.
   PubMedGoogle Scholar
• Yosaee S, Khodadost M, Esteghamati A, Speakman JR, Shidfar F, Nazari MN, Bitarafan V, Djafarian K. 2017. Metabolic syndrome patients have lower levels of adropin when compared with healthy overweight/obese and lean subjects. Am J Mens Health. 11:426–434. doi: 10.1177/1557988316664074.
   PubMed Web of Science ®Google Scholar
• Zhang C, Fang S, Wang H, Zhongyan S, Lai Y. 2022. Factors related to metabolic syndrome development and recovery in Chinese adults: a prospective longitudinal study. Front Endocrinol (Lausanne). 13:923650–923659. doi: 10.3389/fendo.2022.923650.
   PubMed Web of Science ®Google Scholar
• Zhu JZ, Yu CH, Li YM. 2014. Betatrophin provides a new insight into diabetes treatment and lipid metabolism (review). Biomed Rep. 2:447–451. doi: 10.3892/br.2014.284.
   PubMedGoogle Scholar